Search

everythinglearnresearchcommunity

for

Search:↓

Hair and scalp health needs more attention in medical training.

MRI helps evaluate androgenetic alopecia severity.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Restoring skin bacteria may help reduce hair loss.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Androgenetic alopecia patients have a higher risk of metabolic syndrome.

PRP can improve hair growth in androgenetic alopecia, but results vary.

Mesotherapy is a promising alternative to minoxidil for hair loss with mild side effects.

Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Certain cannabinoids may help increase hair growth and could be useful for treating hair loss.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Hair loss caused by genetics and hormones; more research needed for treatments.

Hair loss may increase heart disease risk.

Detailed history and physical examination are crucial for diagnosing hair loss.

Higher RBP4 levels found in people with two types of hair loss.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

CD44 variant changes start alopecia areata, but don't maintain it.